iCrowd Newswire
28 May 2022, 05:02 GMT+10
The global blood and plasma components market is projected to reach $66.47 billion in terms of revenue by 2031, at a CAGR of 4.90%, suggests the premium market intelligence study by BIS Research.
The scope of the report exclusively covers market juggernauts and emerging companies offering blood and plasma components for various end-users. The study considers the transfusion market and plasma-derived products.
The transfusion market consists of packed red blood cells, frozen plasma, and platelet products. Plasma-derived products consist of immunoglobulins, albumins, coagulation factor concentrates, and proteinase inhibitors that are provided by companies in the blood and plasma components ecosystem.
In the comprehensive study of the global blood and plasma components market, BIS Research extensively covers the following:
The detailed study is a compilation of 28 market data tables and 158 figures spread through 228 pages and in-depth TOC on "Global Blood And Plasma Components Market – Analysis And Forecast, 2021-2031"
Demand – Drivers and Limitations
The increasing burden of cancer, hematologic malignancies, and organ transplantation is contributing to the growth of the market. An increase in research and development into the use of plasma components for the treatment of neurological disorders such as chronic inflammatory demyelinating polyneuropathy (CIDP) is also promoting the growth of the market.
Moreover, initiatives taken by the major players in the global blood and plasma components market to expand and launch more blood and plasma collection centers across the world in order to fulfill the supply of blood and plasma are the major factors that are expected to fuel the growth of the market.
Reasons to Buy This Report
This exclusive report on the global blood and plasma components market will help you in the following ways:
Analyst's Take on the Market:
According to Nitish Kumar, Lead Analyst, BIS Research, "Blood is considered as one of the precious sources as there's no other alternative to the human blood and the benefits that it provides in various forms. The reason for market growth can be attributed to the increasing the rising burden of primary immunodeficiency diseases such as hemophilia A, von Willebrand disease (vWD), and secondary immunodeficiency diseases. Further, the increasing burden of cancer, hematologic malignancies, and organ transplantation is also contributing to the growth of the market. An increase in research and development into the use of plasma components for the treatment of neurological disorders such as chronic inflammatory demyelinating polyneuropathy (CIDP) is also promoting the growth of the market. Moreover, initiatives taken by the major players in the global blood and plasma components market to expand and launch more blood and plasma collection centers across the world in order to fulfill the supply of blood and plasma components are the major factors that are expected to fuel the growth of the market."
View the report on Global Blood And Plasma Components Market
Key Companies Operating in the Market and Competitive Landscape
Key insights have been drawn from in-depth interviews with the key opinion leaders of 15 leading companies, market participants, and vendors. The key players operating in the global blood and plasma components market include CSL Limited, Grifols, S.A., Takeda Pharmaceutical Company Limited, ADMA Biologics, Inc., GC Pharma, Octapharma AG, Kedrion S.p.A, Bio Products Laboratory Holding Limited, LFB S.A., Emergent BioSolutions, Inc., American Red Cross, Versiti, Inc., Blood Centers of America, Carter BloodCare, and Memorial Blood Centers.
Who should buy this report?
Request for a FREE sample of this report
Key Questions Answered in the Report:
BIS Research Related Market Studies:
Axial Spondyloarthritis Market
Hematological Malignancies Emerging Therapeutics Market
About BIS Research:
BIS Research is a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends which can disrupt the market dynamics in the near future. We publish more than 200 market intelligence studies annually that focus on several deep technology verticals.
Our strategic market analysis emphasizes on market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.
BIS Research offers syndicate as well as custom studies and expert consultations to firms, providing them specific and actionable insights on novel technology markets, business models, and competitive landscape.
BIS Healthcare vertical offers intelligence in the healthcare technology market for Medical Devices, Digital Health, Life Sciences, Robotics and Imaging, Information Technology, Precision Medicine, and other emerging healthcare technologies, covering the entire industry spectrum. In the past 5 years, BIS Healthcare has published more than 50 reports under the precision medicine banner. Additionally, BIS Research has been nominating Top 25 Voices in Precision Medicine on its Insight Monk platform for the past two years successfully.
Contact:
Head of Marketing
Email: media@bisresearch.com
BIS Research Inc.
39111 PASEO PADRE PKWY STE 313,
FREMONT CA 94538-1686
Visit our Blog @ https://bisresearch.com/news
Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research
Connect with us on Twitter@ https://twitter.com/BISResearch
Tags: medical science, Market Report, Healthcare, Market Research, blood and plasma, deep technology, technology, Healthcare Trends
See Campaign: https://bit.ly/3LXr51D
media@bisresearch.com
Tags:Financial Content, Reportedtimes, iCN Internal Distribution, Extended Distribution, Research Newswire, EnglishGet a daily dose of Denver Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Denver Sun.
More InformationISTANBUL, Turkey: Turkish police detained dozens of people after local authorities banned Istanbul's annual Pride parade from going ahead this ...
PARIS, France: Amidst shortages and soaring prices caused by Russia's invasion of Ukraine and subsequent supply cuts, the heads of ...
WASHINGTON D.C.: In the latest in a series of sanctions aimed at further isolating Russia economically over its invasion of ...
MAGWAY, Myanmar - At least eight resistance fighters were killed on Wednesday when junta troops intercepted a truck they were ...
SHANGHAI, China: As Shanghai reports no new cases of Covid for the first time in two months, Shanghai's top communist ...
WASHINGTON D.C.: The White House has reported that the U.S., Australia, Japan, New Zealand and the UK have created an ...
SAN FRANCISCO, California: General Motors' self-driving Cruise division has begun charging fares for driverless rides in San Francisco.Earlier this month, ...
WASHINGTON D.C.: The U.S. Food and Drug Administration (FDA) is preparing to order Juul Labs to stop selling its e-cigarettes ...
Freddie Freeman, Will Smith and Cody Bellinger hit home runs Wednesday as the Los Angeles Dodgers avoided a three-game sweep ...
The Denver Nuggets and Washington Wizards are finalizing a four-player trade, multiple outlets reported Wednesday. The Nuggets would send guard ...
The Colorado Rockies are having little trouble beating the National League West-leading Los Angeles Dodgers so far this season. Colorado ...
Cleveland hitting coach Chris Valaika said he knows how the Guardians need to play baseball. "We have to play with ...